Daily Archives: April 8, 2021
ESC Position Statement: Diagnosis and treatment of cardiac amyloidosis
8 Apr, 2021 | 08:49h | UTC
Commentary on Twitter (thread – click for more)
ESC position paper on diagnosis & treatment of cardiac amyloidosis published today simultaneously at EHJ & EJHF. https://t.co/ad7xn7c1MYhttps://t.co/pZ6tOWICpn@escardio @ESC_Journals @ehj_ed @MarcoMetra
Thread??(1/7) pic.twitter.com/ngsscfd0pB— Pablo Garcia-Pavia (@dr_pavia) April 7, 2021
RCT: New shorter regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease
8 Apr, 2021 | 08:47h | UTC
Perspective: Special diets might boost the power of drugs to vanquish cancers
8 Apr, 2021 | 08:43h | UTCSpecial diets might boost the power of drugs to vanquish cancers – Science
NICE Guideline: Assessment and Management of Chronic Pain in Over 16s
8 Apr, 2021 | 08:54h | UTC
Large study finds 1 in 3 Covid-19 survivors have subsequent mental health and neurological conditions
8 Apr, 2021 | 09:14h | UTCCommentaries: 1 in 3 Covid-19 patients are diagnosed with a neuropsychiatric condition in the next six months, large study finds – STAT AND A longer look at COVID-19 and neuropsychiatric outcomes – The Lancet Psychiatry AND Largest study to date suggests link between COVID-19 infection and subsequent mental health and neurological conditions – The Lancet AND Covid-19: One in three has neurological or psychiatric condition diagnosed after covid infection, study finds – The BMJ AND One in three survivors of severe Covid diagnosed with mental health condition – The Guardian AND Covid-19 linked to depression and dementia, study suggests – BBC AND Expert reaction to observational study looking at neurological and psychiatric outcomes 6 months after COVID-19 – Science Media Centre AND 1 in 3 COVID Survivors Struggle With Mental Health Issues Months Later – HealthDay
Commentary on Twitter (thread – click for more)
?HUGE STUDY—One in 3 #COVID19 survivors received a neurological diagnosis within 6 months of infection—1 in 8 with first ever diagnosis, says study of 230,000 patient records. Also COVID patients had higher risk of dementia, anxiety, Parkinson’s vs flu.?https://t.co/BlhtUrOsvL pic.twitter.com/ZAcHZviGKR
— Eric Feigl-Ding (@DrEricDing) April 7, 2021
Cohort study: One in ten have long-term effects 8 months following mild COVID-19
8 Apr, 2021 | 09:12h | UTCOne in ten have long-term effects 8 months following mild COVID-19 – Karolinska Institutet
Original study: Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers – JAMA
Commentary on Twitter
#LongCovid in #Frontline: JAMA
Worrisome! N=323 COVID+ #Healthcare Workers vs. N=1072 w no COVID. At 8 mos, up to 4x risk of fxnl impairment in work, social & home life. REAL ongoing suffering in low-risk humans after #COVID.https://t.co/EwZWdW4ZtL#medtwitter #nurse pic.twitter.com/tofIx4p647— WesElyMD (@WesElyMD) April 7, 2021
Study: Outdoor transmission accounts for 0.1% of Covid-19 cases
8 Apr, 2021 | 09:11h | UTCOutdoor transmission accounts for 0.1% of State’s Covid-19 cases – The Irish Times
Meta-Analysis: Primary prevention of variceal bleeding in people with esophageal varices due to liver cirrhosis
8 Apr, 2021 | 08:45h | UTCRelated Cochrane Review: M-A: Secondary prevention of variceal bleeding in adults with previous esophageal variceal bleeding due to decompensated liver cirrhosis
Perspective | Evidence isn’t Everything – Evidence-based medicine and statin decision-making
8 Apr, 2021 | 08:41h | UTCEvidence isn’t Everything – Evidence-based medicine and statin decision-making
Commentary on Twitter
My latest substack on using EBM for medical decisions.
Mike, a middle-aged active person, has been told to take a #statin
Should he?
Mentions in the post — @AndrewFoy82 @LuisCLCorreia @ProfDFrancis @DrJHoward @RogueRad @ProfHayward https://t.co/XJ6eBQ7Zj7
— John Mandrola, MD (@drjohnm) April 7, 2021
Review: Care for the organ transplant recipient on the intensive care unit
8 Apr, 2021 | 08:36h | UTCCare for the organ transplant recipient on the intensive care unit – Journal of Critical Care
Podcast: Evaluation and Management of Chronic Diarrhea
8 Apr, 2021 | 08:38h | UTC#267 Diarrhea Disemboweled Part 2: Chronic Diarrhea with Dr. Iris Wang – The Curbsiders
See also: #266 Diarrhea Disemboweled Part 1: Acute Diarrhea with Dr. Iris Wang – The Curbsiders
Review: Regional anesthesia in patients at risk of bleeding
8 Apr, 2021 | 08:37h | UTCRegional anaesthesia in patients at risk of bleeding – BJA Education
UK regulator confirms that people should continue to receive the COVID-19 vaccine AstraZeneca
8 Apr, 2021 | 09:05h | UTC
Commentary on Twitter
Following suspensions by some countries of the COVID-19 Vaccine AstraZeneca over suspected blood clots, the MHRA confirms that the benefits of the vaccine in preventing COVID-19 far outweigh the risks. People should still go and get their COVID-19 vaccine https://t.co/zse5RUIct1
— Antibiotic Steward??Bassam Ghanem (@ABsteward) April 7, 2021
WHO Interim statement: A causal relationship between the AstraZeneca COVID-19 vaccine and the occurrence of blood clots with low platelets is considered plausible but is not confirmed
8 Apr, 2021 | 09:09h | UTC
Commentary on Twitter (thread – click for more)
? Interim statement of the #COVID19 subcommittee of the WHO Global Advisory Committee on Vaccine Safety on the AstraZeneca vaccine https://t.co/p8XMMAiUne pic.twitter.com/7DMRNFxQsX
— World Health Organization (WHO) (@WHO) April 7, 2021
AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets. The benefits of the vaccine continue to outweigh the risks for people who receive it.
8 Apr, 2021 | 09:07h | UTCCommentaries: In rare instances, AstraZeneca’s Covid-19 vaccine linked to blood clots, regulators say – STAT AND Expert reaction to statements from MHRA and EMA in relation to the AstraZeneca vaccine and rare blood clots and low blood platelets – Science Media Centre
JCVI statement on use of the AstraZeneca COVID-19 vaccine: “JCVI currently advises that it is preferable for adults aged <30 years to be offered an alternative COVID-19 vaccine, if available.”
8 Apr, 2021 | 09:02h | UTCJCVI statement on use of the AstraZeneca COVID-19 vaccine: 7 April 2021 – GOV.UK
Commentaries: Covid: Under-30s offered alternative to Oxford-AstraZeneca jab – BBC AND Expert reaction to statements from MHRA and EMA in relation to the AstraZeneca vaccine and rare blood clots and low blood platelets – Science Media Centre
Video: Coronavirus Variants and Vaccines
8 Apr, 2021 | 09:00h | UTCCoronavirus Variants and Vaccines – JAMA
Study finds low risk of venous thromboembolism in outpatients with Covid-19 – researchers advise against the use of anticoagulants outside clinical trials
8 Apr, 2021 | 08:59h | UTCCommentaries: VTE Related to SARS-CoV-2 Infection Less Of a Problem in Outpatients – TCTMD AND No Increase Seen in Outpatient VTE for SARS-CoV-2-Positive Patients – Physician’s Weekly
Commentary on Twitter (thread – Click for more)
Interesting report on VTE incidence in COVID-19 patients, starting with counting outside of the hospital. See https://t.co/XJvbrfHm6d … 1/n
— Geert-Jan Geersing (@gjgeersing) April 7, 2021